Private Equity
Viola Ventures, formerly known as Carmel Ventures, has raised over $170 million toward its fifth fund. The target is $200 million. The fund will invest in Israeli or Israeli-related early stage companies.
3 min read · 01 November 2017
Brighteye Ventures, a European edtech-focused venture firm, has closed its debut fund at 50 million euros. The fund will lead or participate in Series A or B rounds for edtech companies; it will also consider making acquisitions. Brighteye Venture Advisers is the fund's adviser.
3 min read · 01 November 2017
Frazier Healthcare Partners announced the close of an oversubscribed Frazier Life Sciences IX, its second dedicated life sciences fund, with nearly $419 million in commitments. Led by Managing General Partners Patrick Heron and Jamie Topper, the Frazier life sciences team invests primarily in therapeutics-focused companies developing biopharmaceuticals, with two-thirds of the fund fueling seed and Series A rounds. Exits from 2017 include AnaptysBio (IPO) and Alpine Immune Sciences (reverse merger).
1 min read · 01 November 2017
2 min read · 01 November 2017
2 min read · 01 November 2017
7 min read · 31 October 2017
3 min read · 31 October 2017
Alsop Louie Partners has set out to raise a $125 million fourth venture fund, according to a filing with the SEC.
1 min read · 31 October 2017
Klingenstein Fields Wealth Advisors is seeking to raise $50 million for a venture fund, according to an SEC filing. The New York City-based firm provides financial and investment advice.
1 min read · 31 October 2017
NRD Capital Management LLC has made an investment in New York City-based FundRx, a venture capital platform that invests in healthcare and life sciences startups. No financial terms were disclosed.
4 min read · 31 October 2017
